CDN1163
CAS No. 892711-75-0
CDN1163( CDN 1163 | CDN-1163 )
Catalog No. M16438 CAS No. 892711-75-0
CDN1163 (CDN-1163) is a small molecule, allosteric activator of SERCA2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 58 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 52 | In Stock |
|
| 10MG | 85 | In Stock |
|
| 25MG | 155 | In Stock |
|
| 50MG | 245 | In Stock |
|
| 100MG | 398 | In Stock |
|
| 200MG | 579 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDN1163
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDN1163 (CDN-1163) is a small molecule, allosteric activator of SERCA2.
-
DescriptionCDN1163 (CDN-1163) is a small molecule, allosteric activator of SERCA2, dose-dependently increases the Vmax of SERCA2 Ca2+-ATPase activity in ER microsomes; increases Ca2+-ATPase activity and significantly enhances Ca2+ uptake into the ER, attenuates H2O2-stimulated cell death in HEK cells; improves glucose homeostasis and metabolic parameters, increases glucose tolerance in ob/ob mice; CDN1163 reduces lipid accumulation and decreases lipogenesis in obese mice livers.
-
In VitroCDN1163 (10μM; 24 hours; rat cardiac myocyte cells) treatment reduces high glucose-induced resistin and nuclear NFATc expression and increases the phosphorylation of AMPKα in a time-dependent manner. Western Blot Analysis Cell Line:Rat cardiac myocyte cells (H9c2)Concentration:10?μM Incubation Time:24 hours Result:High glucose-induced resistin and nuclear NFATc expression are significantly reduced. The phosphorylation of AMPKα is increased in a time-dependent manner.
-
In VivoCDN1163 (50 mg/kg; intraperitoneal injection; for 5 days; male ob/ob mice and lean ob/+ mice) increases SERCA2 Ca2+-ATPase activity, decreases endoplasmic reticulum (ER) stress-induced cell death in vitro and improves liver Ca2+ transport activity. CDN1163 reduces blood glucose levels and improves metabolic parameters and gluconeogenic gene expression, reverses hepatic steatosis, inhibits ER stress and ER stress-induced apoptosis, and improves mitochondrial efficiency in ob/ob mice in vivo. Animal Model:Male 8-10-week old ob/ob mice and lean ob/+ mice Dosage:50 mg/kg Administration:Intraperitoneal injection; for 5 days Result:Markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight. Increased expression of uncoupling protein 1 (UCP1) and UCP3 in brown adipose tissue and reduced the hepatic expression of genes involved in gluconeogenesis and lipogenesis, attenuated ER stress response and ER stress-induced apoptosis, and improved mitochondrial biogenesis, possibly through SERCA2-mediated activation of AMP-activated protein kinase pathway.
-
SynonymsCDN 1163 | CDN-1163
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number892711-75-0
-
Formula Weight320.392
-
Molecular FormulaC20H20N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 156.06 mM; H2O : < 0.1 mg/mL
-
SMILESO=C(NC1=C2N=C(C)C=CC2=CC=C1)C3=CC=C(OC(C)C)C=C3
-
Chemical Name4-(1-Methylethoxy)-N-(2-methyl-8-quinolinyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Krajnak K, et al. Bioorg Med Chem Lett. 2018 May 15;28(9):1591-1594.
2. Kang S, et al. J Biol Chem. 2016 Mar 4;291(10):5185-98.
3. Dahl R. Bioorg Med Chem. 2017 Jan 1;25(1):53-57.
4. Cornea RL, et al. J Biomol Screen. 2013 Jan;18(1):97-107.
molnova catalog
related products
-
Etripamil
Etripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells. Etripamil is an antagonist of short-acting L-type calcium-channel.
-
Ginsenoside-Rf
Ginsenoside Rf is a trace component of ginseng root. Ginsenoside Rf inhibits N-type Ca2+ channel.
-
Amlodipine Besylate
Amlodipine Besylate is a long-acting calcium channel blocker.
Cart
sales@molnova.com